Skip to content
MedsAcross

Medicine

Nizatidine 150 mg capsule

Nizatidine · Oral
Available on requestPrescription onlyUS FDAGeneric name

Nizatidine 150 mg capsule is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Nizatidine
Brand
Sold under the generic name
Strength
150 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 500 capsules, 30 capsules and 5 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaEpic PharmaActavis Pharma
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A02BA04 Nizatidine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
9 July 2002
Identifiers
RxCUI 198041, 312025DailyMed set ID 367a1004-59c1-4474-a4f6-ce8bf5a1b043, faaa7cc4-fda9-d5b8-de2a-71c8744ccb76, e9957997-8b85-48a0-9bb3-b878cb223236NDC 0591-3137, 55111-310, 42806-299Application ANDA075616, ANDA077314, ANDA076178

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 capsule in 1 bottle55111-310-01Dr. Reddy's LaboratoriesIndia15 September 2005
500 capsule in 1 bottle55111-310-05Dr. Reddy's LaboratoriesIndia15 September 2005
30 capsule in 1 bottle55111-310-30Dr. Reddy's LaboratoriesIndia15 September 2005
60 capsule in 1 bottle55111-310-60Dr. Reddy's LaboratoriesIndia15 September 2005
10 blister pack in 1 carton / 10 capsule in 1 blister pack55111-310-78Dr. Reddy's LaboratoriesIndia15 September 2005
60 capsule in 1 bottle, plastic0591-3137-60Actavis Pharma9 July 2002
30 capsule in 1 bottle42806-299-30Epic Pharma25 October 2024
60 capsule in 1 bottle42806-299-60Epic Pharma25 October 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 12 April 1988Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Nizatidine

Clinical summary

Nizatidine is a histamine-2 receptor antagonist indicated for up to 8 weeks for the treatment of active duodenal ulcer, among other approved uses. It is available as capsules and oral solution. MedsAcross supplies Nizatidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Nizatidine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Nizatidine 150 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.